A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors

NCT07269899 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor Cancer
Cancer

Interventions

DRUG: WTX212A injection
RADIATION: radiotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]